Clinical trial
Multi-center Cross-sectional Epidemiological Study to Characterize the Prevalence and Distribution of Lipoprotein(a) Levels Among Patients With Established Cardiovascular Disease
NCT03887520 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-center Cross-sectional Epidemiological Study to Characterize the Prevalence and Distribution of Lipoprotein(a) Levels Among Patients With Established Cardiovascular Disease
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 27, 2018
- Completion date
- July 30, 2021
- Enrollment
- 49,001 (actual)
- Sites
- 900
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease and lipoprotein(a)